INOVIO PHARMACEUTICALS, INC. — Director's Dealing 2021

May 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOVIO PHARMACEUTICALS, INC. (INO)
CIK: 0001055726
Period of Report: 2021-05-13

Reporting Person: Weiner David B. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-14	Common Stock	M	8700	—	Acquired	859836	Direct
2021-05-17	Common Stock	S	3045	$6.62	Disposed	856791	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-13	Common Stock Options	$6.23	A	27000	Acquired	2031-05-13	Common Stock (27000.0)	Direct
2021-05-13	Restricted Stock Unit	$	A	18000	Acquired		Common Stock (18000.0)	Direct
2021-05-14	Restricted Stock Unit	$	M	8700	Disposed		Common Stock (8700.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 14, 2021.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer.

F3: This grant was made pursuant to the issuer's non-employee director compensation policy.

F4: Options to vest 100% on May 13, 2022.

F5: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 13, 2022.